Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Recruiting
Observational Study
Atopic Dermatitis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 – 89
- Sex
- Any
- Study type
- Observational
- Participants needed
- 450 (estimated)
- Sponsor
- Castle Biosciences Incorporated · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in ski…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants may be eligible if they:
* Are 12 to 89 years old.
* Have been diagnosed with atopic dermatitis (eczema).
* Have had at least one atopic dermatitis flare within the past 2 months.
* Are willing and able to use the Nevisense Go device at home, complete an electronic…
Contacts